[Effectiveness of preventive treatment by Influenzinum in the winter period against the onset of influenza-like illnesses]

Therapie. 2017 Sep;72(4):465-474. doi: 10.1016/j.therap.2016.12.011. Epub 2017 Feb 17.
[Article in French]


Aim: In vitro Influenzinum induce a cellular change. We present the results of the first study examining the effectiveness of Influenzinum against influenza-like illnesses.

Method: Retrospective cohort study during winter 2014-2015. After influenza epidemic, a self-assessment questionnaire was offered to patients presenting for a consultation. The primary endpoint was the declaration of an influenza-like illness. The exposed patients (treated by Influenzinum) were matched to two non-exposed patients (untreated) with a propensity score. A conditional logistic model expressed influenza-like illness risk reduction provided by the Influenzinum.

Results: The cohort included 3514 patients recruited from 46 general practitioners. After matching, the treated group (n=2041) and the untreated group (n=482) did not differ on variables collected. Influenzinum preventive therapy does not significantly alter the likelihood of influenza-like illness (adjusted odds ratio=0,91 [0,62 to 1,35], p=0,64).

Conclusion: Influenzinum preventive therapy did not appear effective in preventing influenza-like illness.

Keywords: Active immunization; Ambulatory care; Grippe humaine; Homeopathy; Homéopathie; Human influenza; Influenzinum; Médecine ambulatoire; Propensity score; Score de propension; Vaccination.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cohort Studies
  • Female
  • France
  • Humans
  • Influenza Vaccines / therapeutic use*
  • Influenza, Human / prevention & control*
  • Male
  • Matched-Pair Analysis
  • Middle Aged
  • Retrospective Studies
  • Seasons
  • Young Adult


  • Influenza Vaccines